Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as art. Additionally we are shipping MMP 9 Kits (124) and MMP 9 Proteins (65) and many more products for this protein.
Showing 10 out of 449 products:
Human Monoclonal MMP 9 Primary Antibody for EIA, IHC (fro) - ABIN371659
Steffensen, Wallon, Overall: Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. in The Journal of biological chemistry 1995
Show all 12 references for ABIN371659
Human Polyclonal MMP 9 Primary Antibody for IHC (p), WB - ABIN390154
Behrens, Mathiak, Mangold, Kirdorf, Wellmann, Fogt, Rothe, Florin, Wernert: Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. in International journal of cancer. Journal international du cancer 2003
Show all 8 references for ABIN390154
Human Polyclonal MMP 9 Primary Antibody for EIA, IHC (p) - ABIN358703
Zhao, Chang, Trevino, Whren, Bhawan, Klempner: Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease. in The Journal of infectious diseases 2003
Show all 5 references for ABIN358703
Human Polyclonal MMP 9 Primary Antibody for IF (p), IHC (p) - ABIN668095
Zhao, Xu, He, Hua, Luo, Zuo: Expression of serum response factor in gastric carcinoma and its molecular mechanisms involved in the regulation of the invasion and migration of SGC-7901 cells. in Cancer biotherapy & radiopharmaceuticals 2013
Show all 4 references for ABIN668095
Human Polyclonal MMP 9 Primary Antibody for IF (p), IHC (p) - ABIN873171
Deng, Zhong, Gu, Shen, Guo: MiR-21 involve in ERK-mediated upregulation of MMP9 in the rat hippocampus following cerebral ischemia. in Brain research bulletin 2013
Show all 4 references for ABIN873171
Cow (Bovine) Polyclonal MMP 9 Primary Antibody for IHC, WB - ABIN2777743
Nozell, Ma, Wilson, Shah, Benveniste: Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression. in The Journal of biological chemistry 2004
Show all 3 references for ABIN2777743
Human Polyclonal MMP 9 Primary Antibody for IHC (fro), IHC (p) - ABIN113587
Fiorentino, Tallents, Miller, Brouxhon, OBanion, Puzas, Kyrkanides: Spinal interleukin-1beta in a mouse model of arthritis and joint pain. in Arthritis and rheumatism 2008
Show all 2 references for ABIN113587
Human Polyclonal MMP 9 Primary Antibody for EIA, WB - ABIN953468
Lacchini, Jacob-Ferreira, Luizon, Coeli, Izidoro-Toledo, Gasparini, Ferreira-Sae, Schreiber, Nadruz, Tanus-Santos: Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients. in Clinica chimica acta; international journal of clinical chemistry 2010
Show all 2 references for ABIN953468
Human Polyclonal MMP 9 Primary Antibody for WB - ABIN223235
Hountis, Ikonomidis, Stamatelopoulos, Douzinas: Compression of the right atrium due to coexistence of diaphragmatic eventration and Chilaiditi's syndrome. in The Thoracic and cardiovascular surgeon 2008
Show all 2 references for ABIN223235
Human Polyclonal MMP 9 Primary Antibody for IHC, ELISA - ABIN1533355
Matsumoto, Niimi, Kohyama: Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis. in Cellular immunology 2012
129/SvEv mice are more susceptible to abdominal aortic aneurysms compared to C57Bl/6 mice and suggest roles for MMP2 (show MMP2 Antibodies)/9.
In diabetic retinopathy transcription of MMP-9 is regulated by AP-1 binding at both, proximal and distal sites of its promoter, and acetylation of c-Jun and c-Fos subunits is important in its regulation.
Fusion peptide inhibitors of MMP-8 (show MMP8 Antibodies)/-9 prevent endotoxic shock if administered within a strict time window.
Report cross-talk between macrophages, smooth muscle cells, and endothelial cells in response to cigarette smoke alters MMP2 (show MMP2 Antibodies)/9 levels.
These data indicate that oxygen-glucose deprivation-triggered Cav-1 (show CAV1 Antibodies) S-nitrosylation interacts with tPA (show PLAT Antibodies)-induced ERK (show EPHB2 Antibodies) activation to augment MMP2 (show MMP2 Antibodies) and 9 secretion and subsequent extracellular matrix degradation.
Type IV collagenases, MMP-2 (show MMP2 Antibodies) and MMP-9, play important roles in hair cycle, and this could be mediated by induced expression of VEGF (show VEGFA Antibodies), IGF-1 (show IGF1 Antibodies), and TGF-beta (show TGFB1 Antibodies).
Found hyperexpression of exogenous hypoxia response element-matrix metalloproteinase-9 under the control of hypoxia, and its expression was mainly located in neurons and astrocytes without aggravation of blood brain barrier damage.
Early MMP-2 (show MMP2 Antibodies)/MMP (show MMP2 Antibodies)-9 activity is not a determinant of long-term recovery after traumatic brain injury in the immature mouse.
CXCR4 (show CXCR4 Antibodies) inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2 (show MAPK1/3 Antibodies) expression.
MMP-9 mediates thrombus-induced loss of vein wall compliance by increasing stiffness of the extracellular matrix and collagen-elastin (show ELN Antibodies) fibers during thrombus resolution.
MMP-9 C(-1562)T polymorphism is significantly associated with risk of stroke in patients with and without T2DM.
To investigate the relationship between matrix metalloproteinase 9 (MMP-9) gene polymorphism and the efficacy of glucocorticoid therapy in idiopathic pulmonary fibrosis (IPF) patients
The expression levels of matrix metalloproteinase 9 significantly decreased at 50 microM (P<0.05). Further, it suppressed cell motility by downregulating the expression of matrix metalloproteinase (show MMP20 Antibodies).
These results indicate that our hydrophilic extract from P. oceanica might be a source of new pharmacological natural products for treatment or prevention of several diseases related to an altered MMP-2 (show MMP2 Antibodies) and MMP-9 expression.
Results show that TSG101 (show TSG101 Antibodies) bidirectionally modulates cell invasion through regulating MMP-9 mRNA expression in different cell types.
At baseline, NGAL (show LCN2 Antibodies)-MMP-9 levels were significantly higher in active Crohn's disease (CD) patients vs healthy controls. After treatment, NGAL (show LCN2 Antibodies)-MMP-9 levels significantly decreased in completely healed CD patients.
These results show that increased MMP-8 (show MMP8 Antibodies) and decreased TIMP-1 (show TIMP1 Antibodies) expressions are closely related to the invasive pituitary adenoma, and can be helpful for the evaluation.
Genes expression of MMP9, VEGFA (show VEGFA Antibodies) and TIMP1 (show TIMP1 Antibodies) in peripheral blood leukocytes may play a pivotal role in regulation of progression of bladder cancer; TIMP1 (show TIMP1 Antibodies) expression may be important factor for early recurrence.
MMP-9 expression was significantly increased in the dysplastic and neoplastic cases than in nondysplastic cases in ulcerative colitis.
Data suggest that MMP9 expression in white blood cells of subjects with chronic obstructive pulmonary disease (COPD (show ARCN1 Antibodies)) is up-regulated as compared to non-smoking/smoking control subjects; MMP9 may serve as biomarker for progression/severity of COPD (show ARCN1 Antibodies).
Increased MMP-9 expression is associated with carotid atherosclerotic plaque.
Increased expression of MMP-9 is associated with intraplaque hemorrhage in a swine model of vulnerable carotid atherosclerosis
we demonstrated the presence of high molecular weight (HMW) complexes (130, 170, and 220 kDa) containing MMP9, TIMP1 (show TIMP1 Antibodies), and NGAL (show LCN2 Antibodies) (also MMP2 (show MMP2 Antibodies) in 220 kDa complex) without proteolytic activity.
Data demonstrate for the first time that MMP2 (show MMP2 Antibodies) and MMP9 are expressed in swine ovarian follicle both in theca and granulosa layers.
FiO2 used for resuscitation affects matrix metalloproteinases MMP-9 and MMP-2 (show MMP2 Antibodies), caspase-3 (show CASP3 Antibodies) and BDNF (show BDNF Antibodies)
Oxygen for newborn resuscitation increases MMP-2 (show MMP2 Antibodies)/-9 activity resulting in tissue damage and influencing remodeling processes.
contribution of MMPs to the inflammatory breakdown of the blood-CSF (show CSF2 Antibodies) barrier in vitro
The levels of matrix metalloproteinase-2 (show MMP2 Antibodies) and matrix metalloproteinase-9 (MMP-9)in the corpus luteum of swine during luteolysis are reported.
Our data define pericyte interactions as a main inducer of endothelial MMP secretion and propose a new role for pericyte-endothelial cell crosstalk at the BBB (show ALMS1 Antibodies) in vitro
Variable gene expression (eg, matrix metalloproteinase-9, CCL2 (show CCL2 Antibodies) and Lp-PLA(2 (show Lp-PLA2 Antibodies)) mRNAs), both in regard to the arterial bed and duration of disease, was associated with variable plaque development and progression.
The MMP-9 gene was duplicated and differentiated into two genes, one was specialized in a common ancestor of X. laevis and X. tropicalis expressed in degenerating and remodeling organs in response to thyroid hormone (show PTH Antibodies) during metamorphosis.
MMP-9TH is responsible in the larval epithelial apoptosis through degrading ECM (show MMRN1 Antibodies) components in the basal lamina, whereas MMP-9 is involved in the removal of dying epithelial cells during amphibian intestinal remodeling
metamorphic tail and intestine RNA levels of TIMP-2 (show TIMP2 Antibodies), MT1-MMP (show MMP14 Antibodies) and Gel-A, but not MT3-MMP (show MMP24 Antibodies) or TIMP-3 (show TIMP3 Antibodies), are elevated during periods of cell death and proliferation
These data demonstrate that serum neutrophil haptoglobin (show HP Antibodies)-MMP 9 complexes appear sooner and decline more rapidly than other acute phase proteins.
Activation of cytosolic MMP-9 and MMP-2 (show MMP2 Antibodies) was investigated in the retinal endothelial cells incubated in high glucose for 6-96 h, and correlated with their mitochondrial accumulation and mitochondrial damage.
Role of TGF-beta1 (show TGFB1 Antibodies) and TNF-alpha (show TNF Antibodies) in IL-1beta (show IL1B Antibodies) mediated activation of proMMP-9 in pulmonary artery smooth muscle cells: involvement of an aprotinin sensitive protease.
Decreased MMP-9 and increased TIMP-1 (show TIMP1 Antibodies) expression were found in peripheral blood cells from Mycobacterium avium subsp. paratuberculosis (Map)-infected cattle after stimulation with Map lysate and Map purified protein derivative than in control cattle.
We used a trophoblast cell line (F3) derived from bovine placentomes to examine the influence of EGF (show EGF Antibodies) on MMP-9 and TIMP-1 (show TIMP1 Antibodies) expression by semiquantitative RT-PCR and MMP activity by zymography.
results suggest a significant role of matrix metalloproteinase-2 (show MMP2 Antibodies) and-9 in growth and development of bovine follicle
Cells constitutively produced proMMP-9 and proMMP-2, and treatment with TNFalpha (show TNF Antibodies), hepatocyte growth factor (show HGF Antibodies), and 12-O-tetradecanoylphorbol 13-acetate resulted in significant increase in level of proMMP-9 but not in level of proMMP-2.
MMP-2 and MMP-9 production in blastocysts attached to the endometrial cells is regulated by TNF-alpha and TNF-beta
Results suggest that MMP-2 (show MMP2 Antibodies), MMP-9, and TIMP-2 (show TIMP2 Antibodies) mRNAs are expressed in bovine placentomes during the gestational and postpartum periods and that these enzymes, in conjunction with steroidogenic enzymes, mediate fetal membrane detachment after parturition.
Expression of MMP-9 increased after cerebral aneurysm induction, peaking at week 3, leading to reduced smooth muscle cell number, damaged endothelial cells, and damage to the aneurysm wall elastic layer.
Inflammatory factors such as TNF-alpha (show TNF Antibodies) can stimulate MMP-2 (show MMP2 Antibodies)/9 activity in corneal epithelium cells. This may be a potential manipulating mechanism of MMP expression in the pathogenesis of corneal diseases
Therefore, it was reasonable to speculate that the increased expression of VEGF (show VEGFA Antibodies) and MMP-9 in residual hepatic tumor cells and tumor angiogenesis post-embolization would be responsible for the increased metastatic potentiality and invasiveness.
Performing minimally invasive surgical procedures in the early stages of intracerebral hemorrhage significantly decreases MMP-9.
Increased expression of MMP-9 in spinal cord follows cervical spondylotic myelopathy.
Hemoperfusion could obviously reduce oxidative stress and the expression levels of MMP-2 (show MMP2 Antibodies), MMP-9 and TIMP-1 (show TIMP1 Antibodies) in rabbits with acute paraquat poisoning.
In experimental syringomyelia, MMP-9 plays an important role in causing edema in the presyrinx state.
Tongxinluo can inhibit the expression of MMP-3 (show MMP3 Antibodies) and 9 and increase the expression of PPARgamma (show PPARG Antibodies) in atherosclerotic rabbits.
TGF-beta (show TGFB1 Antibodies) mediated MMP-9 induction may be regulated by the NF-kappaB (show NFKB1 Antibodies), Smad3 (show SMAD3 Antibodies), and JNK (show MAPK8 Antibodies) pathways, whereas the IL-1beta (show IL1B Antibodies) mediated induction may be regulated by the NF-kappaB (show NFKB1 Antibodies) and p38 (show MAPK14 Antibodies) pathways.
elevated beta-oxidation-fuelled mitochondria-derived reactive oxygen species within epidermal cells helps guide matrix metalloproteinase (show MMP20 Antibodies)-driven leukocyte recruitment.
Mmp9 regulates both acute and chronic tissue damage and plays an essential role in collagen reorganization during wound repair.
MeHg impairs tail development at least partially by activation of the tissue remodeling proteases Mmp9 and Mmp13 (show MMP13 Antibodies).
study identified mechanism by which mycobacteria induce granulomas: ESAT-6 induced MMP9 in epithelial cells neighboring infected macrophages; MMP9 enhanced recruitment of macrophages, which contributed to nascent granuloma maturation & bacterial growth
From 24h post fertilization, mmp9 expression was detected in a population of circulating white blood cells.
expression and activity of MMP-2 (show MMP2 Antibodies) and MMP-9 in the embryonic zebrafish.
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling.
, Matrix metalloproteinase-9
, 92 kDa gelatinase
, 92 kDa type IV collagenase
, 92-kDa type IV collagenase
, gelatinase B
, matrix metalloproteinase 9 (gelatinase B 92-kDa type IV collagenase)
, matrix metalloproteinase 9 (gelatinase B, 92-kDa type IV collagenase)
, 92kD gelatinase
, 92kD type IV collagenase
, 92kDa gelatinase
, 92kDa type IV collagenase
, Gel B
, collagenase type IVB
, matrix metalloproteinase 9
, macrophage gelatinase
, matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
, type V collagenase
, 75 kDa gelatinase
, type IV collagenase MMP-9
, matrix metalloproteinase 9 (gelatinase B, 92kDa matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)